Rare Case of Late-Onset Narcolepsy Type 1 by Petra Kovalská, Simona Dostálová, Hana Machová, Petra Nytrová, Eszter Maurovich Horvat, Karel Šonka

Get full text

Natalizumab promotes anti-inflammatory and repair effects in multiple sclerosis. by Ragnhild Reehorst Lereim, Petra Nytrova, Astrid Guldbrandsen, Eva Kubala Havrdova, Kjell-Morten Myhr, Harald Barsnes, Frode S Berven

Get full text

Evaluation of a multiparametric immunofluorescence assay for standardization of neuromyelitis optica serology. by Letizia Granieri, Fabiana Marnetto, Paola Valentino, Jessica Frau, Agata Katia Patanella, Petra Nytrova, Patrizia Sola, Marco Capobianco, Sven Jarius, Antonio Bertolotto

Get full text

Blood metabolomic and transcriptomic signatures stratify patient subgroups in multiple sclerosis according to disease severity by Alexandra E. Oppong, Leda Coelewij, Georgia Robertson, Lucia Martin-Gutierrez, Kirsty E. Waddington, Pierre Dönnes, Petra Nytrova, Rachel Farrell, Inés Pineda-Torra, Elizabeth C. Jury

Get full text

SARS-CoV-2 Specific Humoral Immune Responses after BNT162b2 Vaccination in Hospital Healthcare Workers by Maryam Golshani, Ludmila Maffei Svobodová, Lubomír Štěpánek, Jan Zeman, Petra Nytrová, Helena Posová, Petra Petrásková, Olga Novotná, Michaela Nováková, Viktor Černý, Jiří Beneš, Libuše Kolářová, Martin Vokurka, Jiří Hrdý

Get full text

Immunity following SARS-CoV-2 vaccination in autoimmune neurological disorders treated with rituximab or ocrelizumab by Petra Nytrova, Dominika Stastna, Adam Tesar, Adam Tesar, Ingrid Menkyova, Ingrid Menkyova, Helena Posova, Helena Koprivova, Veronika Mikulova, Jiri Hrdy, Gabriela Smela, Dana Horakova, Irena Rysankova, Kristyna Doleckova, Michaela Tyblova

Get full text

Using Serum Metabolomics to Predict Development of Anti-drug Antibodies in Multiple Sclerosis Patients Treated With IFNβ by Kirsty E. Waddington, Kirsty E. Waddington, Artemis Papadaki, Leda Coelewij, Leda Coelewij, Marsilio Adriani, Petra Nytrova, Eva Kubala Havrdova, Anna Fogdell-Hahn, Rachel Farrell, Pierre Dönnes, Pierre Dönnes, Inés Pineda-Torra, Elizabeth C. Jury

Get full text

Clinicogenomic factors of biotherapy immunogenicity in autoimmune disease: A prospective multicohort study of the ABIRISK consortium. by Signe Hässler, Delphine Bachelet, Julianne Duhaze, Natacha Szely, Aude Gleizes, Salima Hacein-Bey Abina, Orhan Aktas, Michael Auer, Jerôme Avouac, Mary Birchler, Yoram Bouhnik, Olivier Brocq, Dorothea Buck-Martin, Guillaume Cadiot, Franck Carbonnel, Yehuda Chowers, Manuel Comabella, Tobias Derfuss, Niek De Vries, Naoimh Donnellan, Abiba Doukani, Michael Guger, Hans-Peter Hartung, Eva Kubala Havrdova, Bernhard Hemmer, Tom Huizinga, Kathleen Ingenhoven, Poul Erik Hyldgaard-Jensen, Elizabeth C Jury, Michael Khalil, Bernd Kieseier, Anna Laurén, Raija Lindberg, Amy Loercher, Enrico Maggi, Jessica Manson, Claudia Mauri, Badreddine Mohand Oumoussa, Xavier Montalban, Maria Nachury, Petra Nytrova, Christophe Richez, Malin Ryner, Finn Sellebjerg, Claudia Sievers, Dan Sikkema, Martin Soubrier, Sophie Tourdot, Caroline Trang, Alessandra Vultaggio, Clemens Warnke, Sebastian Spindeldreher, Pierre Dönnes, Timothy P Hickling, Agnès Hincelin Mery, Matthieu Allez, Florian Deisenhammer, Anna Fogdell-Hahn, Xavier Mariette, Marc Pallardy, Philippe Broët, ABIRISK consortium

Get full text